Skip to main content

Follow us

Home

Search

the Gateway to Research in Oklahoma

  • Researchers
  • Providers
  • Patients
  • About GRO

Gateway to Research in Oklahoma


Oklahoma Shared Clinical and Translational Resources U54 GM104938

Researchers

imgResearchers

The GRO: Researcher Portal provides resources, information, and training to help individuals or communities involved in performing clinical and translational research in Oklahoma.

Providers

imgProviders

The GRO: Provider Portal assists medical providers to identify clinical research opportunities in Oklahoma, tools for patient education, and evidence-based resources to improve patient care.

Patients

imgPatients

The GRO: Patient Portal can help patients and families to learn more about clinical and translational research and to connect with opportunities to participate in research opportunities in your communities.

Oklahoma Research Highlights

Fluorine-containing FDA-approved small-molecule drugs in 2025: significance, synthetic insights, and therapeutic applications

1 month 1 week ago
Fluorine has been widely incorporated into small-molecule drugs as an effective strategy to modulate metabolic stability, lipophilicity, target interactions, and overall pharmacokinetic profile. As a result, fluorine-containing compounds remain well represented among newly approved therapeutics across a broad spectrum of disease areas; notably, in 2025, 14 of the 29 small-molecule drugs approved by the U.S. Food and Drug Administration (FDA) contained at least one fluorine atom, underscoring the...
Shweta Mishra

Emotional Reactions to the Oklahoma City Bombing in Relation to Posttraumatic Stress Disorder in Directly Exposed Survivors

1 month 1 week ago
Existing empirical research examining PTSD related to disaster exposure has generally been limited to quantitative methods and also cross-sectional rather than over time. The purpose of this qualitative study was to retrospectively examine postdisaster emotions emerging over time in highly trauma-exposed disaster survivors, comparing individuals with and without PTSD. Survivors of the 1995 Oklahoma City bombing were interviewed approximately 17 months after the bombing, assessed for PTSD, and...
Elizabeth Whitney Pollio

DARC-NESS: a mastery-based cognitive-behavioral model for treating chronic nightmares in youth

1 month 1 week ago
Theories of chronic nightmare maintenance highlight dysfunctional beliefs about sleep and nightmares, distress and arousal, anticipatory anxiety, maladaptive sleep habits, and sleep deprivation as perpetuating factors that maintain nightmare disorder over time. Theories of nightmare treatment suggest that self-efficacy is a common factor in nightmare mitigation. The current article introduces DARC-NESS, a multi-component theory of nightmare maintenance that emphasizes nightmare self-efficacy as...
Lisa DeMarni Cromer

Understanding the Role of Online Patient-Provider Communication in Patient-Centered Care: A Structural Equation Modeling-Based Multigroup Analysis Comparing Brazil and Portugal

1 month 1 week ago
The proliferation of digital health technologies has transformed healthcare delivery globally. Within this context, online patient-provider communication (OPPC) has emerged as a significant tool for facilitating patient-provider interactions. Using data from Brazil (N = 1,099, M(age) = 37.83) and Portugal (N = 1,011, M(age) = 40.79), this comparative study explored discrepancies in OPPC utilization and related outcomes by examining the relationship between OPPC and healthcare satisfaction....
Jizhou Francis Ye

Empiric azithromycin alters the upper respiratory microbiome and resistome without anti-inflammatory benefit in COVID-19

1 month 1 week ago
Azithromycin is a widely used antibiotic and was frequently used to treat hospitalized patients during the COVID-19 pandemic. The impact of empiric azithromycin use on the respiratory microbiome in patients with viral respiratory infections is unclear. Here we used longitudinal metatranscriptomics on nasal swabs from a prospective multicentre cohort of 1,164 patients hospitalized for COVID-19. We compared the upper respiratory microbiome, resistome and systemic immune response in patients...
Abigail Glascock

Pagination

  • Previous page ‹ Previous
  • Page 138
  • Next page Next ›
Subscribe to

octsi logo

1000 N. Lincoln Blvd, Suite 2100, Oklahoma City, OK 73104
Copyright © 2021 The Board of Regents of the University of Oklahoma, All Rights Reserved.

About GRO

News
Publications
FAQ

Terms of Use

Privacy Policy
Accessibility

Contact

info email
info phone
Copyright © 2026. All rights reserved. Designed By Zymphonies